精神分裂症治疗中的希望是真实还是炒作?医生的角色何在
本文基于精神分裂症患者的体验指出,精神科医生对疾病结局的态度缺乏希望,直接影响治疗中的互信。作者讨论了希望的科學依据,并论证希望在优化精神分裂症最佳治疗策略中具有工具性作用。
要点
- 患者体验显示精神科医生对结局态度缺乏希望,影响治疗互信。
- 希望具有科学依据,并在优化治疗策略中起工具性作用。
- 需关注医生态度对精神分裂症治疗关系的直接影响。
核心结论
- 依据患者体验,精神科医生对精神分裂症结局的态度缺乏希望,并直接影响治疗中的互信。
- 希望具有科学依据,并在优化精神分裂症最佳治疗策略中发挥工具性作用。
主要发现
- 从精神分裂症患者经验看,其精神科医生对疾病结局的态度缺乏希望。
- 医生缺乏希望的态度直接影响治疗中的相互信任。
- 作者讨论希望的科學依据,并展示其在优化治疗策略中的工具性角色。
临床怎么用
- 临床中应关注并反思自身对精神分裂症结局的态度是否缺乏希望。
- 可将希望作为优化精神分裂症治疗策略的工具性要素加以运用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
According to the experience of people with schizophrenia, their psychiatrists' attitude towards the outcome of their illness is lacking in hope, which directly affects mutual faith in treatment. Here we discuss the scientific basis of hope and show its instrumental role in optimising the best treatment strategies for schizophrenia. Declaration of interest R.A.B has received honoraria for educational input and non-financial support from Ache; honoraria for educational input from Lundbeck; grants, honoraria for educational input and non-financial support from Janssen; all outside the submitted work. G.E.M.G. has received honoraria for educational input and non-financial support from Janssen outside the submitted work. G.M. reports support from Janssen-Cilag, outside the submitted work, and is an employee at Janssen-Cilag. S.S. has received grants and honoraria for educational input from EnVivo Pharmaceuticals, Takeda, AbbVie and Janssen Pharmaceuticals, outside the submitted work.
引用
- Bressan RA, Grohs GEM, Matos G, et al. Hope or hype in the treatment of schizophrenia - what's the role of the physician? Br J Psychiatry. 2018. PMID: 29433614. doi:10.1192/bjp.2017.13
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。